Orangekloud Technology Inc. (Class A) (ORKT) carries a Roarable Rating of E (Strong Sell) with 30/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 0.20 (DISTRESS RISK (<1.8)) • Piotroski F-Score 4/9
FRED Regime × Technicals: 20% of 52W Range • RSI-14 at 48.7 (NEUTRAL RANGE)
Capital intensity & 0% operating margin leave 16 pts on the table
While ORKT currently carries a cautious 30/100 (E) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Technology with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.01) and Max Pain ($1.05) forces dealer call-delta covering toward $2.61.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Orangekloud Technology Inc. (Class A) (ORKT) slipped -0.99% to $1.00, trading at 20% of its 52-week range ($0.62 – $2.49). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
Gainers BIO-key International (NASDAQ:BKYI) stock increased by 26.7% to $2.66 during Thursday's pre-market session. The company's market cap stands at $4.6 million. ARB IOT Group (NASDAQ:ARBB) stock increased
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +49.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ORKT today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ORKT. Explore sector supply chains on /butterfly.
Across 714 tracked Technology securities in the Roarable RQD universe, Orangekloud Technology Inc. (Class A) (ORKT) ranks #674 by composite RQD confidence (30/100, grade E) and #667 by equity capitalization ($5.8M). Within this direct 5-issuer industry benchmark cohort, ORKT leads on earnings valuation at N/A trailing P/E, while ORKT leads on capital efficiency and profitability with -35.0% ROIC and 44.2% gross margin. LHSW currently holds the highest overall quantitative score in the immediate peer group at 48/100 (D) compared with ORKT at 30/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ORKT
ACTIVE
Orangekloud Technology Inc. (Class A) | E | 30/100 | — | 44.2% | -35.0% | -0.99% | $5.8M | Benchmark Subject |
| BKYI BIO-key International Inc. | E | 33/100 | — | 76.9% | -35.0% | -6.69% | $6.0M | /bkyi-vs-orkt → |
| GYGY Game Your Game Inc. | D- | 35/100 | — | 8.6% | -35.0% | +7.59% | $5.7M | /gygy-vs-orkt → |
| IFBD Infobird Co. Ltd | D- | 38/100 | — | 29.5% | -35.0% | -7.94% | $6.1M | /ifbd-vs-orkt → |
| LHSW Lianhe Sowell International Group Ltd (Class A) | D | 48/100 | — | 21.4% | — | +9.55% | $6.6M | /lhsw-vs-orkt → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Orangekloud Technology Inc. (Class A) (ORKT) reported GAAP revenue of $4.4M (+49.3% vs. FY2024 revenue of $3.0M ) , GAAP net income of -$3.5M, operating cash flow of -$3.6M, and free cash flow of -$3.8M (+47.2% YoY). On the balance sheet, ORKT closed FY2025 with $9.2M in total assets against $0 in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $4.4M | -$3.5M | -$3.6M | -$3.8M | $9.2M | — |
| FY2024 (FY) | 2024-12-31 | $3.0M | -$6.3M | -$7.3M | -$7.3M | $11.7M | — |
As of 2026-11-01, Orangekloud Technology Inc. (Class A) (NASDAQ: ORKT) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 30/100 at a spot price of $1.00 (-0.99% 1D, market cap $5.8M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 714 tracked Technology issuers, ORKT ranks #674 in composite RQD confidence.
Within the Technology sector (Computer Software: Prepackaged Software), ORKT carries a Roarable E (30/100 RQD), trailing P/E of N/A, gross margin of 44.2%, and ROIC of -35.0%. By comparison, BKYI (BIO-key International Inc.) holds a E grade (33/100 RQD, P/E N/A, ROIC -35.0%, cap $6.0M) and GYGY (Game Your Game Inc.) posts a D- grade (35/100 RQD, P/E N/A, ROIC -35.0%, cap $5.7M). Among the 5-stock peer group, ORKT leads on earnings multiple (N/A) while ORKT leads on capital efficiency (-35.0% ROIC).
Per ORKT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001979407), Orangekloud Technology Inc. (Class A) generated $4.4M in revenue (+49.3% YoY), -$3.5M in net income, and -$3.8M in free cash flow against $9.2M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
ORKT last traded at $1.00 (-0.99% on volume of 109,928 shares), positioning the stock -0.99% below its 50-day simple moving average ($1.01) and -4.76% below its 200-day simple moving average ($1.05). Across its 52-week range of $0.62 to $2.49, ORKT sits at the 20.3% percentile with a 14-day RSI of 48.7 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $1.13).
Why ORKT Stock slipped -0.99% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.